The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Sanctuary Advisors LLC

Sanctuary Advisors LLC raised its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 18.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,609 shares of the medical device company's stock after buying an additional 6,359 shares during the period. Sanctuary Advisors LLC's holdings in Cooper Companies were worth $4,093,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in COO. Wealth Enhancement Advisory Services LLC grew its position in shares of Cooper Companies by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 6,797 shares of the medical device company's stock worth $593,000 after buying an additional 184 shares in the last quarter. Blue Trust Inc. grew its holdings in Cooper Companies by 112.7% during the 2nd quarter. Blue Trust Inc. now owns 553 shares of the medical device company's stock worth $48,000 after acquiring an additional 293 shares in the last quarter. Raymond James & Associates increased its position in Cooper Companies by 4.4% during the 2nd quarter. Raymond James & Associates now owns 647,106 shares of the medical device company's stock valued at $56,492,000 after purchasing an additional 27,442 shares during the period. First Horizon Advisors Inc. raised its holdings in shares of Cooper Companies by 4.8% in the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock valued at $236,000 after purchasing an additional 125 shares in the last quarter. Finally, Fifth Third Bancorp lifted its position in shares of Cooper Companies by 6.3% in the 2nd quarter. Fifth Third Bancorp now owns 8,465 shares of the medical device company's stock worth $739,000 after purchasing an additional 502 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ COO traded up $0.51 during trading hours on Tuesday, reaching $94.49. The stock had a trading volume of 1,938,014 shares, compared to its average volume of 1,170,241. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The stock has a fifty day moving average of $103.26 and a 200 day moving average of $99.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market cap of $18.86 billion, a P/E ratio of 48.46, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.87 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insider Transactions at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company's stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on COO. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Stifel Nicolaus reaffirmed a "buy" rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.